Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI)

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Clostridium Difficile Infection, Clostridium Difficile Infection Recurrence

In brief

The purpose of this study is to gain further knowledge regarding the effectiveness of vancomycin prophylaxis in preventing Clostridium difficile infections in order to guide physicians' practices.

Key facts

Study ID
NCT04000555
Run by
University of South Florida
People needed
26
Starts
2019-09-01
Expected to finish
2022-06-11
Last updated by the study team
2023-04-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.